Intelligence Beyond Baseline
Revalin Access Notice
Research Use Compliance
Revalin is a chemical supplier for legitimate research institutions and professionals. Revalin is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, and is not an outsourcing facility as defined under Section 503B of the Federal Food, Drug, and Cosmetic Act.
All products are provided exclusively for in-vitro and pre-clinical research. They are not for human or veterinary use, consumption, or therapeutic application. By continuing, you confirm your organization has appropriate facilities, trained personnel, and safety controls for lawful handling and accepts responsibility for compliant use.
Research Use Only · User Discretion Advised
CJC-1295 NO DAC
$45.00
Research demonstrates that CJC-1295 NO DAC produces measurable increases in growth hormone and IGF-1, with particularly pronounced effects when combined with ghrelin-mimetic peptides like ipamorelin. Biohackers favor this variant for studies investigating acute GH pulses and short-term axis modulation.
The peptide's mechanism involves pituitary somatotroph cell stimulation through GHRH receptor activation. Research protocols frequently pair this compound with complementary peptides to maximize GH secretion efficiency. Current research focuses on optimal dosing windows, receptor dynamics, and comparative efficacy against the DAC variant.